Onconova therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Onconova therapeutics Contact Number

Contact Us Onconova Therapeutics, Inc.

3 hours ago Onconova.com Get All

267-759-3680Contact - Onconova Therapeutics Inc. CORPORATE: Tel: +1-267-759-3680 Email: [email protected]onconova.us INVESTORS AND MEDIA: Tel: +1-267-759-3036 Email: [email protected]onconova.us

Website: https://www.onconova.com/contact/

Category: Contact SupportShow more

Onconova Therapeutics Crunchbase Company Profile & Funding

1 hours ago Crunchbase.com Get All

Contact Email [email protected]onconova.us. Phone Number 2677593681. Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of targeted anti-cancer agents designed

Founded: 1998

Website: https://www.crunchbase.com/organization/onconova-therapeutics

Category: Contact NumberShow more

Onconova Therapeutics, Inc. A Biopharmaceutical Company

5 hours ago Onconova.com Get All

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova’s novel, proprietary multi-kinase

Website: https://www.onconova.com/

Category: Contact NumberShow more

Onconova Therapeutics, Inc. A Phase 3 stage

Just Now Onconova.org Get All

Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2018 Financial Results May 9, 2018; Onconova Therapeutics to Present at the Disruptive Growth and Healthcare Conference on May 8th, 2018 May 3, 2018; Onconova Therapeutics Announces Closing of $28.75 Million Upsized Underwritten Public Offering May 1, 2018

Website: http://onconova.org/

Category: Contact NumberShow more

Onconova Therapeutics Announces that the Required Number

8 hours ago Investor.onconova.com Get All

267-759-3680Onconova undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events. Press release contact information. Company Contact: Avi Oler Onconova Therapeutics, Inc. 267-759-3680 [email protected]onconova.us

Website: https://investor.onconova.com/news-releases/news-release-details/onconova-therapeutics-announces-required-number-survival-events

Category: Contact NumberShow more

Onconova Therapeutics Employees, Board Members, Advisors

8 hours ago Crunchbase.com Get All

Onconova Therapeutics has 9 current employee profiles, including President, Research and Development Thomas J. McKearn. Onconova Therapeutics has 5 board members and advisors, including Pankaj R. Patel.

Website: https://www.crunchbase.com/organization/onconova-therapeutics/people

Category: Contact NumberShow more

SEC Filing Onconova Therapeutics

5 hours ago Investor.onconova.com Get All

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

Website: https://investor.onconova.com/node/13641/html

Category: Contact NumberShow more

SEC Filing Onconova Therapeutics

5 hours ago Investor.onconova.com Get All

(800) 322-2885For additional information please refer to the proxy statement available at www.sec.gov and Onconova’s investor relations web site at www.onconova.com. If you have any questions, or need assistance in voting, please contact our proxy solicitor MacKenzie Partners, Inc. toll-free at (800) 322-2885.

Website: https://investor.onconova.com/node/13091/html

Category: Contact NumberShow more

Partnering Onconova Therapeutics, Inc.

6 hours ago Onconova.com Get All

KNIGHT THERAPEUTICS INC. November 21, 2019 – Onconova entered into a Distribution, License and Supply Agreement with Knight Therapeutics Inc., a Canadian-based specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription and over-the-counter pharmaceutical products.

Website: https://www.onconova.com/partnering/

Category: Contact NumberShow more

Onconova Therapeutics (ONTX) Company Profile & Overview

6 hours ago Stockanalysis.com Get All

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Its novel proprietary multi-kinase inhibitor ON

Website: https://stockanalysis.com/stocks/ontx/company/

Category: Contact NumberShow more

SEC Filing Onconova Therapeutics

5 hours ago Investor.onconova.com Get All

Onconova Therapeutics, Inc. Notes to Condensed Consolidated Financial Statements (Unaudited) 1. Nature of Business . The Company . Onconova Therapeutics, Inc. (the "Company") was incorporated in the State of Delaware on December 22, 1998 and commenced operations on January 1, 1999. The Company's headquarters are located in Newtown, …

Website: https://investor.onconova.com/node/12851/html

Category: Contact NumberShow more

Onconova Therapeutics Number of Employees 20122021 ONTX

8 hours ago Macrotrends.net Get All

Onconova Therapeutics number of employees from 2012 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Website: https://www.macrotrends.net/stocks/charts/ONTX/onconova-therapeutics/number-of-employees

Category: Contact NumberShow more

Privacy Policy Onconova Therapeutics

Just Now Onconova.com Get All

Onconova Therapeutics, Inc. (“Onconova”) recognizes the importance of protecting the privacy of information it obtains in the course of conducting its business, either through Onconova’s website (the “Website”), or through other means.

Website: https://www.onconova.com/privacy-policy/

Category: Contact NumberShow more

Onconova Therapeutics, Inc. Announces Pricing of $21

9 hours ago Finance.yahoo.com Get All

267-759-3680General Contact. Avi Oler Onconova Therapeutics, Inc. 267-759-3680 [email protected]onconova.us The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 42,672,290

Website: https://finance.yahoo.com/news/onconova-therapeutics-inc-announces-pricing-120000984.html

Category: Contact NumberShow more

Onconova Therapeutics Announces that the Required Number of

6 hours ago Globenewswire.com Get All

Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis Company Contact: Avi Oler Onconova Therapeutics

Website: https://www.globenewswire.com/news-release/2020/07/29/2069696/0/en/Onconova-Therapeutics-Announces-that-the-Required-Number-of-Survival-Events-Has-Been-Reached-for-the-Pivotal-Phase-3-INSPIRE-Trial-Data-Analysis.html

Category: Contact NumberShow more

Onconova Therapeutics Announces that the Required Number

3 hours ago Finance.yahoo.com Get All

Topline INSPIRE Results are Expected by the End of the Third Quarter of 2020NEWTOWN, Pa., July 29, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage

Website: https://finance.yahoo.com/news/onconova-therapeutics-announces-required-number-173000617.html

Category: Contact NumberShow more

ONTX Company Profile for ONCONOVA THERAPEUTICS, INC

2 hours ago Msn.com Get All

Pharmaceuticals. Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing products for patients with cancer. The Company has

Website: https://www.msn.com/en-us/money/stockdetails/company/fi-a1z9lh

Category: Contact NumberShow more

Onconova Therapeutics Announces that the Required Number

1 hours ago Nasdaq.com Get All

Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis Published Jul …

Website: https://www.nasdaq.com/press-release/onconova-therapeutics-announces-that-the-required-number-of-survival-events-has-been

Category: Contact NumberShow more

Onconova Therapeutics Announces that the Required Number

6 hours ago Nz.finance.yahoo.com Get All

267-759-3680Onconova undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.Press release contact informationCompany Contact: Avi Oler Onconova Therapeutics, Inc. 267-759-3680 [email protected]onconova.us https://www

Website: https://nz.finance.yahoo.com/news/onconova-therapeutics-announces-required-number-173000617.html

Category: Contact NumberShow more

What is Onconova Therapeutic Valuation? (NASDAQ:ONTX

1 hours ago Macroaxis.com Get All

Onconova Therapeutic holds a recent Real Value of $2.49 per share. The prevailing price of the company is $5.2. At this time, the company appears to be overvalued.Our model determines the value of Onconova Therapeutic from analyzing the company fundamentals such as Shares Outstanding of 236.61 M, shares owned by institutions of 23.21 %, and Return On Equity of …

Website: https://www.macroaxis.com/valuation/ONTX/Onconova-Therapeutic

Category: Contact NumberShow more

Onconova Therapeutics : View Presentation Slides

8 hours ago Marketscreener.com Get All

Onconova Therapeutics : View Presentation Slides. Preliminary Phase 1/2a Data with Rigosertib and Nivolumab. in Advanced KRAS+ NSCLC Featuring Expert Overview. This presentation contains forward-looking statements about Onconova Therapeutics based on management's current expectations, which are subject to known and unknown uncertainties …

Website: https://www.marketscreener.com/quote/stock/ONCONOVA-THERAPEUTICS-IN-46372025/news/Onconova-Therapeutics-View-Presentation-Slides-36492187/

Category: Contact NumberShow more

www.sec.gov

6 hours ago Sec.gov Get All

EXPLANATORY NOTE . Onconova Therapeutics, Inc., sometimes referred to as “we,” “our,” or the “Company” is filing this Amendment No. 1 on Form 10-K/A, or this Amendment, to its Annual Report on Form 10-K for the year ended December 31, 2020, originally filed on March 18, 2021, or the “Original Report,” for the sole purpose of including the information required by Part III of

Website: https://www.sec.gov/Archives/edgar/data/1130598/000110465921059160/tm211024d4_10ka.htm

Category: Contact NumberShow more

Is Onconova Therapeutics Inc (ONTX) a Winner in the

6 hours ago Investorsobserver.com Get All

Onconova Therapeutics Inc (ONTX) stock is trading at $5.98 as of 9:44 AM on Wednesday, Sep 22, a rise of $1.08, or 22.04% from the previous closing price of $4.90. Volume today is above average. So far 5,665,346 shares have traded compared to average volume of 249,624 shares. The stock has traded between $5.53 and $6.20 so far today.

Website: https://www.investorsobserver.com/news/stock-update/is-onconova-therapeutics-inc-ontx-a-winner-in-the-biotechnology-industry-2

Category: Contact NumberShow more

Onconova Therapeutics Inc (ONTX) is down 7.14% Thursday In

5 hours ago Investorsobserver.com Get All

Onconova Therapeutics Inc has a Long-Term Technical rank of 64. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 36% of the market scoring higher. In the Biotechnology industry which is number 128 by this metric, ONTX ranks better than 80% of stocks. Important Dates for Investors in

Website: https://www.investorsobserver.com/news/stock-update/onconova-therapeutics-inc-ontx-is-down-7-14-thursday-in-premarket-trading

Category: Contact NumberShow more

Onconova Therapeutics Inc (ONTX) is lower by 13.50% Friday

8 hours ago Investorsobserver.com Get All

Onconova Therapeutics Inc has a Long-Term Technical rank of 59. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 41% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, ONTX ranks better than 74% of stocks. Important Dates for Investors in

Website: https://www.investorsobserver.com/news/stock-update/onconova-therapeutics-inc-ontx-is-lower-by-13-50-friday-in-premarket-trading

Category: Contact NumberShow more

Onconova Therapeutics, Inc. Announces Proposed Public

7 hours ago Investor.onconova.com Get All

NEWTOWN, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

Website: https://investor.onconova.com/news-releases/news-release-details/onconova-therapeutics-inc-announces-proposed-public-offering-0

Category: Contact NumberShow more

Onconova Therapeutics Announces that the Required Number

3 hours ago Benzinga.com Get All

NEWTOWN, Pa., July 29, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel

Website: https://www.benzinga.com/pressreleases/20/07/g16834465/onconova-therapeutics-announces-that-the-required-number-of-survival-events-has-been-reached-for-t

Category: Contact NumberShow more

Onconova Therapeutics Inc. (ONTX): The stock short term

9 hours ago Baxterreport.com Get All

The total number of common shares currently owned by the public is 15.78 million. ONTX does have institutional investors; and they hold 19.40% of the stock. Onconova Therapeutics Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 0 new insider purchases involving 0 shares.

Website: https://baxterreport.com/2021/09/20/onconova-therapeutics-inc-ontx-the-stock-short-term-indicators-scream-sell-today-2/

Category: Contact NumberShow more

Onconova Therapeutics Reports Second Quarter 2021

7 hours ago Channelchek.com Get All

(855) 428-5741Onconova will host an investment community conference call today beginning at 4:30 p.m. Eastern Time, during which management will discuss financial results for the second quarter of 2021, provide a business update and answer questions. Interested parties can participate by dialing (855) 428-5741 (domestic callers) or (210) 229-8823

Website: https://www.channelchek.com/news-channel/Release___Onconova_Therapeutics_Reports_Second_Quarter_2021_Financial_Results_And_Provides_Business_Update

Category: Contact NumberShow more

Onconova Therapeutics Inc. (ONTX) Stock Price, Quote

Just Now Channelchek.com Get All

Release - Onconova Therapeutics Announces The Initial Dosing Of The First Patient In The U.S. Phase 1 Clinical Trial Of ON 123300, 05/21/2021 QuickChek - May 21, 2021, 05/21/2021 Release - Aurania Resources Reports Elevated Silver-Zinc Has Been Discovered In Outcrop Over 2.7 Kilometres At Tiria-Shimpia, 05/21/2021

Website: https://www.channelchek.com/company/ONTX

Category: Contact NumberShow more

ONCONOVA THERAPEUTICS, INC. : ONTX Stock Price

7 hours ago Marketscreener.com Get All

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing products for patients with cancer. The Company has created a targeted anti-cancer agent designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

Website: https://www.marketscreener.com/quote/stock/ONCONOVA-THERAPEUTICS-IN-46372025/

Category: Contact NumberShow more

Onconova Therapeutics Provides Corporate Update and Reports

8 hours ago Globenewswire.com Get All

The Company will host a conference call today, May 14, 2020, at 4:30 p.m. Eastern Time, to provide a corporate update and discuss first quarter 2020 financial results. Interested parties may

Website: https://www.globenewswire.com/news-release/2020/05/14/2033864/0/en/Onconova-Therapeutics-Provides-Corporate-Update-and-Reports-First-Quarter-2020-Financial-Results.html

Category: Contact NumberShow more

Onconova Therapeutics Announces Encouraging Clinical Data

3 hours ago Stocktitan.net Get All

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

Website: https://www.stocktitan.net/news/ONTX/onconova-therapeutics-announces-encouraging-clinical-data-supporting-dtfn5vm5nyf7.html

Category: Contact NumberShow more

Contact Us – TG Therapeutics

2 hours ago Tgtherapeutics.com Get All

212-554-4531TG Therapeutics, Inc. 2 Gansevoort Street, 9th Floor. New York, NY 10014. P: 877-575-TGTX (8489) F: 212-554-4531. For Investor Relations & Media Inquiries: Please contact [email protected] For Business Development Inquiries:

Website: https://www.tgtherapeutics.com/contact-us/

Category: Contact SupportShow more

Should You Sell Onconova Therapeutics Inc (ONTX) Stock

9 hours ago Investorsobserver.com Get All

Onconova Therapeutics Inc has fallen 28.03% over the past month, closing at $8.18 on May 10. During this period of time, the stock fell as low as $6.28 and as high as $16.50. ONTX has an average analyst recommendation of Buy. The company has an average price target of $45.73. ONTX has an Overall Score of 48.

Website: https://www.investorsobserver.com/news/stock-update/should-you-sell-onconova-therapeutics-inc-ontx-stock-monday-morning

Category: Contact NumberShow more

ONCONOVA THERAPEUTICS, INC. : Shareholders Board Members

5 hours ago Marketscreener.com Get All

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing products for patients with cancer. The Company has created a targeted anti-cancer agent designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

Website: https://www.marketscreener.com/quote/stock/ONCONOVA-THERAPEUTICS-IN-46372025/company/

Category: Contact NumberShow more

Onconova Therapeutics Reports First Quarter 2021 Financial

9 hours ago Finance.yahoo.com Get All

Onconova will host an investment community conference call today beginning at 4:30 p.m. Eastern time, during which management will discuss financial results for the first quarter of 2021, provide

1. Author: Onconova Therapeutics, Inc.

Website: https://finance.yahoo.com/news/onconova-therapeutics-reports-first-quarter-200500275.html

Category: Contact NumberShow more

Onconova Therapeutics, Inc. (NASDAQ: ONTX) Stock News

3 hours ago Youtube.com Get All

SNNLive spoke with Ramesh Kumar, President & CEO of Onconova Therapeutics, Inc. (NASDAQ: ONTX) at the LD Micro "Main Event" 2016 in Bel Air, CA. For more inf

Website: https://www.youtube.com/watch?v=emmWZjHgiiA

Category: Contact NumberShow more

Onconova Therapeutics Inc(ONTX) Stock Price,News,Quote …

2 hours ago Moomoo.com Get All

09-24 10The U.S. has the highest number o. 09-24 10:29 ET. Onconova Therapeutics Raises $21M Via Equity At 17% Discount. Onconova Therapeutics Inc (NASDAQ:ONTX) has priced an underwritten public offering of 5 million shares at $4.20 for gross proceeds of $21 million.The offer price represents an almost 17% discount at t. 09-24 09:24 ET

Website: https://www.moomoo.com/en-us/stock/ONTX-US

Category: Contact NumberShow more

Onconova Therapeutics Inc. (ONTX): The stock long term

3 hours ago Baxterreport.com Get All

The total number of common shares currently owned by the public is 236.61 million. ONTX does have institutional investors; and they hold 21.80% of the stock. Onconova Therapeutics Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 0 new insider purchases involving 0 shares.

Website: https://baxterreport.com/2021/08/19/onconova-therapeutics-inc-ontx-the-stock-long-term-indicators-say-sell-today/

Category: Contact NumberShow more

Onconova Therapeutics : Proxy Statement 14A MarketScreener

3 hours ago Marketscreener.com Get All

ONCONOVA THERAPEUTICS, INC. Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies:

Website: https://www.marketscreener.com/quote/stock/ONCONOVA-THERAPEUTICS-IN-46372025/news/Onconova-Therapeutics-Proxy-Statement-14A-32493918/

Category: Contact NumberShow more

Onconova Therapeutics, Inc. (ONTX) Stock Price, News

Just Now Stockstelegraph.com Get All

Onconova Therapeutics, Inc. (ONTX) stock rallied over 29.59% intraday to trade at $6.35 share on NASDAQ. The stock opened with a gain of % at $5.67 and touched an intraday high of $6.77, rising 38.16% against the last close of $4.90. The stock went to a low of $5.51 during the session.

Website: https://stockstelegraph.com/quotes/ONTX/

Category: Contact NumberShow more

ONCONOVA THERAPEUTICS, INC. : Target Price Consensus and

7 hours ago Marketscreener.com Get All

Mean consensus: BUY: Number of Analysts: 3: Last Close Price: 5,22 $ Average target price: 20,00 $ Spread / Average Target: 283%

Website: https://www.marketscreener.com/quote/stock/ONCONOVA-THERAPEUTICS-IN-46372025/consensus/

Category: Contact NumberShow more

ONTX Onconova Therapeutics, Inc. Stock Quote

2 hours ago Elite.finviz.com Get All

16-21 04Feb-16-21 04:03PM. Onconova Therapeutics, Inc. Announces Closing of $28.75 Million Public Offering of Common Stock Including Full Exercise of the Over-Allotment Option. GlobeNewswire +5.17%. 08:00AM. Onconova Therapeutics to Present Corporate Update at the 2021 BIO CEO & Investor Digital Conference.

Website: https://elite.finviz.com/quote.ashx?t=ONTX

Category: Contact NumberShow more

Onconova Therapeutics Announces Reverse Stock Split and

1 hours ago Finance.yahoo.com Get All

Onconova’s common stock will continue to trade on the Nasdaq Capital Market under the trading symbol “ONTX.” The new CUSIP number for the common stock following the reverse stock split is

1. Author: Onconova Therapeutics, Inc.

Website: https://finance.yahoo.com/news/onconova-therapeutics-announces-reverse-stock-123200000.html

Category: Contact NumberShow more

Onconova Therapeutics, Inc. Announces Proposed Public

8 hours ago Stocktitan.net Get All

Do NOT follow this link! September 23, 2021 - 4:01 pm. NEWTOWN, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it intends to offer and sell shares of its common …

Website: https://www.stocktitan.net/news/ONTX/onconova-therapeutics-inc-announces-proposed-public-offering-of-xdy7ydtug5x4.html

Category: Contact NumberShow more

MidDay Market Update: Aehr Test Systems Surges Following

Just Now Finance.yahoo.com Get All

Onconova Therapeutics priced an underwritten public offering of 5 million shares at $4.20 for gross proceeds of $21 million. Commodities In commodity news, oil traded up 0.6% to $73.77, while gold

Website: https://finance.yahoo.com/news/mid-day-market-aehr-test-161326115.html

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is Onconova Therapeutics Inc?

Onconova Therapeutics, Inc. - A Biopharmaceutical Company focused on discovering and developing products for patients with cancer. Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer.

Are there any clinical trials for Onconova 123300?

Onconova’s novel, proprietary multi-kinase inhibitor ON 123300 is being evaluated in two separate and complementary Phase 1 dose-escalation and expansion studies. These trials are currently underway in the United States and China.

How to contact TG Therapeutics in New York?

TG Therapeutics, Inc. 2 Gansevoort Street, 9th Floor. New York, NY 10014. P: 877-575-TGTX (8489) F: 212-554-4531. For Investor Relations & Media Inquiries: Please contact [email protected] For Business Development Inquiries:

Popular Brands

Olam
Oracle
Orix
Okta
Oneok
Omv
Orpea
Orsted
Opera
Omron